Cite
APA Citation
Doi, T., Iwasa, S., Muro, K., Satoh, T., Hironaka, S., Esaki, T., Nishina, T., Hara, H., Machida, N., Komatsu, Y., Shimada, Y., Otsu, S., Shimizu, S., Chand, V., & Watanabe, M. (n.d.). 659PAvelumab (anti–PD-L1) in Japanese patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC): Updated results from the phase Ib JAVELIN solid tumour JPN trial. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095321478.0x000041